Literature DB >> 7087018

Complications of thoracoabdominal retroperitoneal lymph node dissection.

D G Skinner, A Melamud, G Lieskovsky.   

Abstract

Mesh:

Year:  1982        PMID: 7087018     DOI: 10.1016/s0022-5347(17)54255-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  8 in total

Review 1.  Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters.

Authors:  C Bokemeyer; M A Kuczyk; J Serth; J T Hartmann; H J Schmoll; U Jonas; L Kanz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

Review 3.  Surgical strategies for postchemotherapy testis cancer.

Authors:  Saum Ghodoussipour; Siamak Daneshmand
Journal:  Transl Androl Urol       Date:  2020-01

4.  Post-chemotherapy robot-assisted retroperitoneal lymph node dissection in non-seminomatous germ cell tumor of testis: Feasibility and outcomes of initial cases.

Authors:  Ekrem İslamoğlu; Çağatay Özsoy; Hakan Anıl; Yasin Aktaş; Mutlu Ateş; Murat Savaş
Journal:  Turk J Urol       Date:  2018-12-20

5.  Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II.

Authors:  J P Donohue; J A Thornhill; R S Foster; R Bihrle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

6.  Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer.

Authors:  J Baniel; R S Foster; R G Rowland; R Bihrle; J P Donohue
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.

Authors:  Axel Heidenreich; David Pfister
Journal:  Ther Adv Urol       Date:  2012-08

8.  The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.

Authors:  G Read; R J Johnson; P M Wilkinson
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.